XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials Wi... ( MENLO PARK Calif. May 15 /- XTENT Inc...)

HOME >> MEDICINE >> NEWS

XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials With the SEC

Date:5/15/2009

MENLO PARK, Calif., May 15 /PRNewswire-FirstCall/ -- XTENT, Inc. ("XTENT" or the "Company") (Nasdaq: XTNT) today announced that its Board of Directors has determined, after consideration of potential strategic alternatives, that it is in the best interests of the Company and its stockholders to liquidate the Company's assets and to dissolve the Company. The Company's Board of Directors has unanimously approved a Plan of Complete Liquidation and Dissolution of the Company (the "Plan of Dissolution") subject to stockholder approval. The Company intends to hold a special meeting of the stockholders to seek approval of the Plan of Dissolution and today it filed related proxy materials with the Securities and Exchange Commission (the "SEC"). Although the Company's Board of Directors has approved the Plan of Dissolution, it will continue to consider any reasonable alternative strategic proposals presented to the Company.

The Plan of Dissolution contemplates an orderly wind down of the Company's business and operations. If the Company's stockholders approve the Plan of Dissolution, the Company intends to file a certificate of dissolution, satisfy or resolve its remaining liabilities and obligations, including contingent liabilities and costs associated with the liquidation and dissolution, make reasonable provisions for unknown claims and liabilities, and make distributions to its stockholders of cash available for distribution, subject to applicable legal requirements. Following stockholder approval of the Plan of Dissolution and the filing of the certificate of dissolution, the Company plans to delist its common stock from the NASDAQ Global Market.

IMPORTANT ADDITIONAL INFORMATION HAS BEEN FILED WITH THE SEC.

This press release is for informational purposes only. It is not a solicitation of a proxy. In connection wit
'/>"/>

1

GOOD

Page: 1 2 3
Related medicine news :

1. Thoratec Announces Appointment of Paul LaViolette to Board of Directors
2. HealthWarehouse.com, Inc. Announces Completion of Business Combination With Clacendix, Inc.
3. Smith & Nephew Orthopaedics Announces First Contribution to OREF Grants Fund
4. Cigna Medical Group Announces Grand Opening of CareToday Clinic in Anthem, Ariz.
5. Americans United for Life Announces Legal Prospectus on Probable Supreme Court Nominees
6. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2009 Financial Results
7. Ontario Systems Announces New Alliance With Microsoft
8. Boston Scientific Announces Schedule for EuroPCR 2009
9. Exiqon Announces New Grant Program for MicroRNA Research
10. May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO
11. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology

Post Your Comments:

XTENT, Inc. Announces Approval of Plan of Liquidation and Dissolution by Board of Directors and Filing of Proxy Materials Wi...( MENLO PARK Calif. May 15 /- XTENT Inc...),Health